P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series

Slični predmeti

• Anifrolumab for the treatment of refractory chilblain lupus erythematosus
  od: Michael J. Woodbury, BS, i dr.
  Izdano: (2024-06-01)
• Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
  od: Michelle Petri, i dr.
  Izdano: (2023-01-01)
• Management of Refractory Lupus Nephritis
  od: Antonis Fanouriakis, i dr.
  Izdano: (2015-07-01)
• Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
  od: Panagiotis Garantziotis, i dr.
  Izdano: (2022-05-01)
• Changing paradigms in the treatment of systemic lupus erythematosus
  od: Antonis Fanouriakis, i dr.
  Izdano: (2019-12-01)